Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm.

Olivier Hermine, Orianne Debeaupuis, Gandhi-Laurent Damaj, Johannes Lübke, Juliana Schwaab, Marc Heizmann, Frank Siebenhaar, Polina Pyatilova, Nicole Nojarov, Marek Niedoszytko, Aleksandra Górska, Mattias Mattsson, Khalid Shoumariyeh, Stephan de Bra, Friederike Wortmann, Nikolas von Bubnoff, Horia Bumbea, Delia Soare, Chiara Elena, Judit Varkonyi, Anna Belloni Fortina, Simge Erdem, Knut Brockow, Tobias Franz, Jens P Panse, Deborah Christen, Christine Breynaert, Akif Selim Yavuz, Luca Malcovati, Michael Doubek, Vito Sabato, Ilaria Tanasi, Massimiliano Bonifacio, Karin Hartmann, Axel Rüfer, Mariarita Sciumè, Valentina Bellani, Irena Angelova-Fischer, Alex Stefan, Massimo Triggiani

DOI: 10.1182/blood.2026035465

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.